S
Sancy A. Leachman
Researcher at Oregon Health & Science University
Publications - 245
Citations - 9037
Sancy A. Leachman is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Melanoma & Cancer. The author has an hindex of 50, co-authored 229 publications receiving 7890 citations. Previous affiliations of Sancy A. Leachman include Mayo Clinic & Yale University.
Papers
More filters
Journal ArticleDOI
Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009
Vinzenz Oji,Gianluca Tadini,Masashi Akiyama,Claudine Blanchet Bardon,Christine Bodemer,Emmanuelle Bourrat,Philippe Coudiere,John J. DiGiovanna,Peter M. Elias,Judith Fischer,Philip Fleckman,Michal Gina,John I. Harper,Takashi Hashimoto,Ingrid Hausser,Hans Christian Hennies,Daniel Hohl,Alain Hovnanian,Alain Hovnanian,Akemi Ishida-Yamamoto,W. K. Jacyk,Sancy A. Leachman,Irene M. Leigh,Juliette Mazereeuw-Hautier,Leonard M. Milstone,Fanny Morice-Picard,Amy S. Paller,Gabriele Richard,Matthias Schmuth,Matthias Schmuth,Hiroshi Shimizu,Eli Sprecher,Maurice A.M. van Steensel,Alain Taieb,Jorge R. Toro,Pierre Vabres,Anders Vahlquist,Mary L. Williams,Heiko Traupe +38 more
TL;DR: An international consensus is achieved for the classification of inherited ichthyosis that should be useful for all clinicians and can serve as reference point for future research.
Journal ArticleDOI
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL
Alisa M. Goldstein,May Chan,Mark Harland,Elizabeth M. Gillanders,Nicholas K. Hayward,Marie-Françoise Avril,Esther Azizi,Giovanna Bianchi-Scarrà,D. Timothy Bishop,Brigitte Bressac-de Paillerets,William Bruno,Donato Calista,Lisa A. Cannon Albright,Florence Demenais,David E. Elder,Paola Ghiorzo,Nelleke A. Gruis,Johan Hansson,David W. Hogg,Elizabeth A. Holland,Peter A. Kanetsky,Richard F. Kefford,Maria Teresa Landi,Julie Lang,Sancy A. Leachman,Rona M. MacKie,Veronica Magnusson,Graham J. Mann,Kristin B. Niendorf,Julia A. Newton Bishop,Jane M. Palmer,Susana Puig,Joan Anton Puig-Butille,Femke A. de Snoo,Mitchell S. Stark,Hensin Tsao,Margaret A. Tucker,Linda Whitaker,Emanuel Yakobson,Joseph Malvehy,Celia Badenas,R. Cervera,Francisco Cuellar,Francisco Cuellar,Rosa M. Martí,Joan Brunet-Vidal,Guang Yang,Nicholas G. Martin,David C. Whiteman,Adèle C. Green,Joanne F. Aitken,Paola Minghetti,Michela Mantelli,Lorenza Pastorino,Sabina Nasti,Sara Gargiulo,Sara Gliori,Sushila Mistry,Juliette Randerson-Moor,Wilma Bergman,Jeanet A.C. ter Huurne,Clasine van der Drift,Leny van Mourik,Coby Out-Luiting,Frans A. van Nieuwpoort,Valérie Chaudru,Agnès Chompret,Caroline Kanengiesser,J. L. Michel,Florent Grange,B. Sassolas,Jean -Marc Limacher,D. Couillet,F. Truchetet,J. P. Cesarini,F. Boitier,Jacqueline Chevrant-Breton,Christine Lasset,Michel Longy,Pascal Joly,Nicole Basset-Seguin,T. Lesimple,Catherine Dugast,Arupa Ganguly,Michael Ming,Patricia Van Belle,Anton Platz,Suzanne Egyhazi,Rainer Tuominen,Diana Linden,Helen Schmid,Alon Scope,Felix Pavlotsky,Eitan Friedman,Mark J. Eliason,Christian Ingvar,Åke Borg,Johan Westerdahl,Anna Måsbäck,Håkan Olsson +99 more
TL;DR: This GenoMEL study provides the most extensive characterization of mutations in high-risk melanoma susceptibility genes in families with three or more melanoma patients yet available and there was little evidence for an association between CDKN2A mutations and NST, but there was a marginally significant association between NST and ARF.
Journal ArticleDOI
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents
Alisa M. Goldstein,May Chan,Mark Harland,Nicholas K. Hayward,Florence Demenais,D. Timothy Bishop,Esther Azizi,Wilma Bergman,Giovanna Bianchi-Scarrà,William Bruno,Donato Calista,Lisa A. Cannon Albright,Valérie Chaudru,Agnès Chompret,Francisco Cuellar,David E. Elder,Paola Ghiorzo,Elizabeth M. Gillanders,Nelleke A. Gruis,Johan Hansson,David W. Hogg,Elizabeth A. Holland,Peter A. Kanetsky,Richard F. Kefford,Maria Teresa Landi,Julie Lang,Sancy A. Leachman,Rona M. MacKie,Veronica Magnusson,Graham J. Mann,Julia A. Newton Bishop,Jane M. Palmer,Susana Puig,Joan Anton Puig-Butille,Mitchell S. Stark,Hensin Tsao,Margaret A. Tucker,Linda Whitaker,Emanuel Yakobson +38 more
TL;DR: The variation in CDKN2A mutations for the four features across continents is consistent with the lower melanoma incidence rates in Europe and higher rates of sporadic melanoma in Australia, which reflects the divergent spectrum of mutations in families from Australia versus those from North America and Europe.
Journal ArticleDOI
Melanocytes as Instigators and Victims of Oxidative Stress
TL;DR: The current knowledge about melanin and the redox state of melanocytes, how paracrine factors help counteract oxidative stress, the role of oxidative stress in melanoma initiation and progression and in melanocyte death in vitiligo is reviewed, and how this knowledge can be harnessed for melanoma and Vitiligo treatment is reviewed.
Journal ArticleDOI
First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
Sancy A. Leachman,Robyn P. Hickerson,Mary E. Schwartz,Emily E. Bullough,Stephen L. Hutcherson,Kenneth M. Boucher,C. David Hansen,Mark J. Eliason,G. Susan Srivatsa,Douglas J. Kornbrust,Frances J.D. Smith,W.H. Irwin McLean,Leonard M. Milstone,Roger L. Kaspar +13 more
TL;DR: The callus regression seen on the patient's siRNA-treated foot appears sufficiently promising to warrant additional studies of siRNA in this and other dominant-negative skin diseases.